Tower Research Capital LLC (Trc) Biote Corp. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Biote Corp. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,410 shares of BTMD stock, worth $5,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,410
Previous 2,194
35.73%
Holding current value
$5,738
Previous $12,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BTMD
# of Institutions
91Shares Held
18.6MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$18.5 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$9.91 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$6.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$5.82 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$5.5 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $30.8M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...